Brian Cobb
Investor Relations Speaker
Replay available
Aquestive Therapeutics, Inc. (AQST) Q3 2025 Earnings Call
Aquestive Therapeutics, Inc. (NASDAQ: AQST) Q3 2025 earnings conference call, held 2025-11-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dan Barber
Chief Executive Officer
Ernie Toth
Chief Financial Officer
Sherry Korchinski
Chief Commercial Officer
David Emselem
Analyst, Piper Sandler
Rick Miller
Analyst, Cantor Fitzgerald (on behalf of Kristin Klasko)
Raghuram Silvarayu
Analyst, HC Wainwright & Co.
Andreas Argerais
Analyst, Oppenheimer & Co.
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Aquestive Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:03.776 Thank you for standing by. Welcome to the Q3 2025 00:00:03.776 -- 00:00:06.901 Equestive Therapeutics, Inc. Earning Conference Call. 00:00:06.901 -- 00:00:09.925 At this time, all participants are in a listen-only mode. 00:00:09.925 -- 00:00:13.249 After the speaker's presentation, there will be a question and answer session. 00:00:13.249 -- 00:00:17.796 To ask a question during this session, you will need to press star 1-1 on your telephone. 00:00:17.796 -- 00:00:21.060 You will then hear an automated message, advise your hand is raised. 00:00:21.060 -- 00:00:24.145 To withdraw your question, please press star 1-1 again. 00:00:24.145 -- 00:00:27.109 Please be advised that today's conference is being recorded. 00:00:27.109 -- 00:00:30.898 I would now like to hand the conference over to your speaker today, Brian Cobb, please 00:00:30.898 -- 00:00:33.319 go ahead, sir. 00:00:33.481 -- 00:00:37.105 Thank you, operator. Good morning, and welcome to today's call. 00:00:37.105 -- 00:00:41.871 On today's call, I'm joined by Dan Barber, Chief Executive Officer, and Ernie Toth, Chief 00:00:41.871 -- 00:00:45.575 Financial Officer. We're going to provide an overview of the company's recent business 00:00:45.575 -- 00:00:50.581 developments and performance for the third quarter of 2025, followed by a Q&A session. 00:00:50.581 -- 00:00:52.883 During the Q&A session, the team will be joined by Dr. 00:00:52.883 -- 00:00:58.317 Gary Slatko, Interim Chief Medical Officer, Sherry Korchinski, Chief Commercial Officer, 00:00:58.317 -- 00:01:03.505 Laurie Brander, Chief Legal Officer, and Peter Boyd, Chief People Officer. 00:01:03.505 -- 00:01:07.030 As a reminder, the company's remarks today correspond with the earnings release that 00:01:07.030 -- 0...